Thousands of American service members and civilians have been killed or wounded in Iraq at the hands of a Shiite terrorist group known as Jaysh al-Mahdi (also known as the Mahdi Army or JAM).
We allege that large multinational pharmaceutical and medical-supply companies funded these terrorists.
Our case presents evidence that these multinational corporations paid bribes to win business from the terrorist-controlled Iraqi Ministry of Health. We allege that the bribes secured large Iraqi government contracts and more profits for these companies. As alleged, these bribes financed Jaysh al-Mahdi terrorist attacks against Americans.
The defendants being sued are the parent companies and/or subsidiaries of AstraZeneca plc, General Electric Co., Johnson & Johnson, Pfizer Inc., and Roche Holding Ltd. In response to our complaint, the defendants have argued, among other things, that Jaysh al-Mahdi is not a “terrorist organization” and thus that the American families in this case cannot hold the defendants accountable under the Anti-Terrorism Act even if it is true that the defendants paid large bribes to Jaysh al-Mahdi members to win big contracts from the Iraqi Ministry of Health. We strongly disagree with the defendants' argument that a corporation cannot be held legally responsible under the Anti-Terrorism Act even if it paid millions directly to Jaysh al-Mahdi when the terrorist group was regularly attacking Americans, and this is one of the things we believe our case is about.
You can view the complaint below or download a PDF copy by clicking the link below.